Nanotechnologies for drug delivery: Application to cancer and autoimmune diseases

Brannon-Peppas, 2004, Adv Drug Deliv Rev, 56, 1649, 10.1016/j.addr.2004.02.014 Brigger, 2002, Adv Drug Deliv Rev, 54, 631, 10.1016/S0169-409X(02)00044-3 Koping-Hoggard, 2005, Expert Rev Vaccines, 4, 185, 10.1586/14760584.4.2.185 Youssef, 1988, Antimicrob Agents Chemother, 32, 1204, 10.1128/AAC.32.8.1204 Gref, 2002, Macromolecules, 35, 9861, 10.1021/ma021132a Brigger, 2002, J Pharmacol Exp Ther, 303, 928, 10.1124/jpet.102.039669 Calvo, 2002, Eur J Neurosci, 15, 1317, 10.1046/j.1460-9568.2002.01967.x de Kozak, 2004, Eur J Immunol, 34, 3702, 10.1002/eji.200425022 Lambert, 2001, Biochem Biophys Res Commun, 279, 401, 10.1006/bbrc.2000.3963 Gref R, Amiel C, Sebille B, Couvreur P. French Patent No. 02 08766; 2002.